Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Elisavet Moutzouri

6PUBLICATIONS
38CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Theoretical quantum chemistryOncology and carcinogenesis not elsewhere classifiedExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Mar 05, 2026
[Controversies in familial dyslipidemias and cardiovascular genetics in 2026].

Maximilien Fleury, Elisavet Moutzouri, Baris Gencer

|Dec 12, 2024
Associations Between Subclinical Thyroid Dysfunction and Cardiovascular Risk Factors According to Age and Sex.

Oliver Baretella, Manuel R Blum, Nazanin Abolhassani

|Feb 07, 2024
Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Sylvain Bétrisey, Moa Lina Haller, Orestis Efthimiou

|May 27, 2023
Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.

Elisavet Moutzouri, Matthias Glutz, Nazanin Abolhassani

|Dec 24, 2022
Lipid-Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta-Analysis of Exclusion Criteria.

Martina Aeschbacher-Germann, Nathalie Kaiser, Alexandre Speierer

|Jul 06, 2021
Subclinical thyroid function and cardiovascular events in patients with atrial fibrillation.

Elisavet Moutzouri, Christina Lyko, Martin Feller

Pageof 1

Frequent Collaborators

4 joint publications

Nicolas Rodondi

3 joint publications

Manuel R Blum

3 joint publications

Drahomir Aujesky

3 joint publications

Baris Gencer

2 joint publications

Alexandre Speierer

2 joint publications

Douglas C Bauer

2 joint publications

Cinzia Del Giovane

2 joint publications

Martin Feller

1 joint publications

Martina Aeschbacher-Germann

1 joint publications

Nathalie Kaiser

Frequent Collaborators

4 joint publications

Nicolas Rodondi

3 joint publications

Manuel R Blum

3 joint publications

Drahomir Aujesky

3 joint publications

Baris Gencer

Top Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on : Sep 15, 2018

8.6K
Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on : Sep 27, 2024

800
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on : Nov 10, 2017

14.6K
See more related videos

Top Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on : Sep 15, 2018

8.6K
Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on : Sep 27, 2024

800
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on : Nov 10, 2017

14.6K
See more related videos